Study finds "extraordinary" genetic diversity in tumors

03/7/2012 | Reuters

About two-thirds of genetic mutations in samples from primary tumors of kidney cancer patients were different from one another, even if they were taken from the same tumor, a British study revealed. Researchers also found even more genetic differentiation in biopsies of secondary tumors. The findings in the New England Journal of Medicine suggest that using samples from a primary tumor as a basis for treatment decisions may not be sufficient, researchers said.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA